A Bayesian cost-benefit approach to sample size determination and evaluation in clinical trials
<p>Current practice for sample size computations in clinical trials is largely based on frequentist or classical methods. These methods have the drawback of requiring a point estimate of the variance of treatment effect and are based on arbitrary settings of type I and II errors. They also do...
Autor principal: | Kikuchi, T |
---|---|
Altres autors: | Gittins, J |
Format: | Thesis |
Idioma: | English |
Publicat: |
2011
|
Matèries: |
Ítems similars
-
Bayesian analysis in expert systems
per: Spiegelhalter, D, et al.
Publicat: (1993) -
An approximate sampling formula under genetic hitchhiking
per: Etheridge, A, et al.
Publicat: (2006) -
A Bayesian approach to the evolution of metabolic networks on a phylogeny
per: Mithani, A, et al.
Publicat: (2010) -
Models and software for improving the profitability of pharmaceutical research
per: Qu, S
Publicat: (2011) -
Synonymous codon usage influences the local protein structure observed
per: Saunders, R, et al.
Publicat: (2010)